The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Performance of a Nu.Q H3.1 assay for lung cancer detection.
 
Anne Louise Louise Sibille
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche Belgium; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst)
 
Monique Henket
No Relationships to Disclose
 
Marielle Herzog
Employment - Volition RX
Leadership - Volition RX
Stock and Other Ownership Interests - Volition RX
Patents, Royalties, Other Intellectual Property - patents (Inst)
Travel, Accommodations, Expenses - Volition RX
 
Natalie Hardat
No Relationships to Disclose
 
Jean-Louis Corhay
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Chiesi; GlaxoSmithKline; Novartis
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Chiesi (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Renaud Louis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Chiesi; GlaxoSmithKline; Novartis
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Chiesi (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Bernard Duysinx
Research Funding - Roche (Inst)